hackettg

/hackettg

About hackettg

This author has not yet filled in any details.
So far hackettg has created 150 blog entries.

Drug Tariff Watch – February 2025

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – February 2025 appeared first on Community Pharmacy England.

By |January 29th, 2025|Lexpos News|Comments Off on Drug Tariff Watch – February 2025

Drug Tariff Watch – January 2025

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 January 2025. From 1 January 2025, Original Pack Dispensing (+/-10% OPD) rules have been introduced in The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) [...]

The post Drug Tariff Watch – January 2025 appeared first on Community Pharmacy England.

By |December 23rd, 2024|Lexpos News|Comments Off on Drug Tariff Watch – January 2025

MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited)

MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) Drug alert number: EL (24)A/61 Date issued: 4 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) DMRC reference number:DMRC-34033472 Company [...]

The post MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) appeared first on Community Pharmacy England.

By |December 4th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited)

MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited)

MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) Drug alert number: EL (24)A/59 Date issued: 2 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) DMRC reference number: DMRC-33616486 Company name: [...]

The post MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) appeared first on Community Pharmacy England.

By |December 2nd, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited)

Drug Tariff Watch – December 2024

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 December 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – December 2024 appeared first on Community Pharmacy England.

By |November 28th, 2024|Lexpos News|Comments Off on Drug Tariff Watch – December 2024